NYSE · Healthcare
$653.70
▲ +$5.27(+0.81%)10:58 AM ET - vs previous closeiQuote as of Sep 17, 2026, 10:58 AM EDT
Realtime NYSE quote as of Sep 17, 2026, 10:58 AM EDT.
Market data source
Evidence
86/100
Strong evidence
Session
+0.81%
vs 648.43 prior close
52-week range
98%
of the 435.27–658.4 range
Consensus target
-1.3%
to 645.15 consensus
TECHi stance
Balanced watch
Model confidence 75/100 · 67/76 inputs
Chart
Latest 1D session
1Y · daily bars · USD · Live $653.70 · 255 pts
Live checkTrade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Investor playbook
The current snapshot gives bulls more to work with, but the watch list still controls timing.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Trend support
+21.8%Current price is above the 200-day average.
Cash yield
3.0%$7.32B free-cash-flow base.
Estimate revisions
+24 net24 EPS estimate increases vs 0 cuts in 30 days.
Catalysts and positioning checks that are not duplicate live-pulse metrics.
Latest catalyst
YahooThermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
Upcoming events
TMO reports on Oct 20, 2026 during the BMO session.
Countdown
33 days out
As of Sep 17, 2026, 10:58 AM EDT, Thermo Fisher Scientific (TMO) traded at $653.70, a +0.81% move versus the prior close, ranging between $649.00 and $658.40 intraday, and on volume of 752.07K shares. The stock has traded between $435.27 and $658.40 over the past 52 weeks, carries a market capitalization of $241.53B, trades at 35.10x trailing earnings, and yields 0.3% in dividends. Sell-side analysts rate TMO Buy across 36 ratings and carry an average price target of $645.15 (-1.31% implied versus the last quote). TMO's record close stands at $672.34, set on Dec 31, 2021.
Buy analyst tone. Latest catalyst: Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’ (Yahoo).
| Enterprise value | $240.84B |
| Price / sales | 5.21 |
| Price / book | 4.59 |
| Operating margin | 17.58% |
| Return on assets | 6.16% |
| EPS (TTM) | $18.61 |
| Beta (5Y) | 0.85 |
Benchmark context
Compare against the broad market.
Help · FAQ
2 answers covering latest price.
TECHi displays provider-supplied values only when the corresponding field is present.
TECHi.com